|
Intravenous MitoTargeted AAV9 Gene Therapy for Treatment of Visual Loss and Encephalopathy in Leigh Syndrome and NARP |
5R01EY027414-04 |
YU, HONG |
NEI |
2020 |
|
Integrative modeling and dynamic prediction of Alzheimers disease |
1 R01 AG064803-01 |
LUO, SHENG |
NIA |
2020 |
|
Towards a better understanding of genetic architecture of Alzheimers disease with human iPSC models |
1 R01 AG065611-01A1 |
WEN, ZHEXING |
NIA |
2020 |
|
Mapping Molecular and Phenotypic Interactions in Alzheimers Disease |
1 R01 AG066490-01 |
MONTGOMERY, STEPHEN BLAIR |
NIA |
2020 |
|
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease |
1 R01 AG066707-01 |
CHENG, FEIXIONG |
NIA |
2020 |
|
Uncoupling Age- Versus Cognitive-Related Cellular Senescence in Alzheimers Disease |
1 R01 AG068279-01 |
BENDALL, SEAN CURTIS |
NIA |
2020 |
|
Using long-range technologies as a multi-omic approach to understand Alzheimers disease in brain tissue |
1 R01 AG068331-01 |
EBBERT, MARK T W |
NIA |
2020 |
|
Shape Memory Polymer Scaffolds to Treat Bone Defects in Patients with Alzheimers Disease |
1 R03 AG067140-01 |
HAHN, MARIAH S |
NIA |
2020 |
|
TOWARD 3D HUMAN BRAIN-LIKE TISSUES FOR TARGETING DYSREGULATED SYNAPSE AND PROTEOSTASIS MECHANISMS IN ALZHEIMERS DISEASE |
1 R03 AG067970-01 |
HAHN, MARIAH S |
NIA |
2020 |
|
Identification of Bacterial Genes that Disrupt Host Proteostasis |
1 R03 AG069056-01 |
CZYZ, DANIEL MILOSZ |
NIA |
2020 |